Table 1 Frequency of ILN in liver metastases from colorectal cancer according to treatment

From: Comment on ‘Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab’

 

No treatment, N =29

CT only, N =31

CT+Beva, N =31

P-valuea

Presence of ILN

0 (0%)

12 (39%)

21 (68%)

P<0.001

Lack of ILN

29 (100%)

19 (61%)

10 (32%)

 
  1. Abbreviations: Beva=bevacizumab; CT=chemotherapy; ILN=infract-like necrosis.
  2. aχ2-test.
Back to article page